HAWPF (Haw Par) Short-Term Debt : $26.9 Mil (As of Jun. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Haw Par Short-Term Debt?

Haw Par's Short-Term Debt for the quarter that ended in Jun. 2024 was $26.9 Mil.

Haw Par's quarterly Short-Term Debt stayed the same from Jun. 2023 ($0.0 Mil) to Dec. 2023 ($0.0 Mil) but then increased from Dec. 2023 ($0.0 Mil) to Jun. 2024 ($26.9 Mil).

Haw Par Short-Term Debt Historical Data

The historical data trend for Haw Par's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haw Par Short-Term Debt Chart

Haw Par Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

Haw Par Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Short-Term Debt	Get a 7-Day Free Trial															9.34	-	-	-	26.85

Haw Par Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Haw Par Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Haw Par's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Haw Par Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haw Par Corp Ltd (OTCPK:HAWPF) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

H02:Singapore

Address

401 Commonwealth Drive, No. 03-03 Haw Par Technocentre, Singapore, SGP, 149598

Website

https://www.hawpar.com

Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, and Others segment. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates a majority of its revenue from the ASEAN countries.

Haw Par Headlines

From GuruFocus

Haw Par Stock Is Believed To Be Significantly Overvalued

By GF Value GF Value • 03-31-2021

First Eagle Comments on Haw Par

By Holly LaFon Holly LaFon • 04-24-2018

Singapore Based Haw Par Selling at a Discount to NAV

By Holmes Osborne, CFA Holmes Osborne, CFA • 07-26-2016